ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVCT Avacta Group Plc

48.80
3.80 (8.44%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.80 8.44% 48.80 48.00 49.00 49.00 45.00 45.00 5,721,464 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.51 137.55M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 45p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £137.55 million. Avacta has a price to earnings ratio (PE ratio) of -3.51.

Avacta Share Discussion Threads

Showing 2851 to 2874 of 79800 messages
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older
DateSubjectAuthorDiscuss
02/8/2017
21:03
Interesting.
But I still want to know,Why do you think bad news is coming?

lantanatony
02/8/2017
18:27
E1nstein

Do you be read RNS ?

I count 5 or 6 so far this year

lentjes
02/8/2017
17:42
What proof do you have that Alastair is "running around the country with the begging bowl"?
e1nstein
02/8/2017
17:15
Why else would Alastair be running around the country with the begging bowl unless the cash from the last fund raise was running low and no sign of revenue.

If cash was not a problem his time would be better spent increasing revenue with contracts and not chasing investors for more money.

lentjes
02/8/2017
16:27
Why expecting bad news?
Where do you get that from?

lantanatony
02/8/2017
14:27
Looks like trading update due and expecting bad news although volume low.

Maybe being dropped for a placing as Alastair has been doing the rounds lately with the collection tin

lentjes
19/7/2017
15:31
There was a positive trading statement issued last year on 1st August.

Since then:

Positive results RNS 22nd September 16
First Affimer pre-clinical 1st November 16
CAR-T collaboration 2nd November 16
Affinity separation 23rd November 16
Immunogenicity Results 3rd April 17
Diagnostic firm deal 24th April 17
Two leading US Biotech's RNS 22nd May 17

Together with the ongoing collaborations (Moderna et al) the cash position will make for interesting reading, as will any deals that might be signed where we qualify for royalties.... our own cancer therapeutic remains the single-most transformational item in the pipeline, so let us all hope that one or more of these is coming close to fruition, and the market starts liking AVCT. For me, we are in the best position we ever have been as a business, but are unappreciated by the market based on past failings. Here's to a step change in appreciation soon.

the drewster
10/7/2017
12:54
Avacta’s Chief Executive Alastair Smith presents at our Manchester seminar tomorrow located at Double Tree by Hilton Manchester Piccadilly. See for more details.
sharesoc
04/7/2017
18:30
If you have not already booked a place for our Manchester seminar on the 11th July, it may be of interest and well worth attending:

Avacta’s Chief Executive Alastair Smith, will be delivering the presentation and will be open to questions!

sharesoc
03/7/2017
13:22
Anyone know what today's excitement is about? Price shot up almost like a news item.
mrangry2
29/6/2017
09:27
Cheers for that E.....
spekky
28/6/2017
08:58
Interesting article just appeared in a very reputable on-line journal showing Affimers working in lots of fancy applications. Might not understand much of it but it shows how widely Affimers can be used which is obviously important. Paste this link into your browser if you want to read it.

hxxp://lens.elifesciences.org/24903

e1nstein
27/6/2017
15:49
Avacta present at our next Manchester growth company seminar on the 11th July, which may be of interest to potential investors and current shareholders. More details at:
sharesoc
19/6/2017
19:31
Avacta presented at our London company seminar on the 14th June, their presentation slides are available on ShareSoc's member network, here:

To access the slides, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here:

Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the slides (and reports on 100s of other meetings). If you're already a member and have any difficulty accessing the presentation slides, please do not hesitate to contact us here:

sharesoc
08/6/2017
16:07
With every passing week there is cashburn ... eventually, this has to stop.

There is circumstantial evidence (details tied up in confidentiality clauses) that some commercial deals have reduced pressure, but until hard figures are released, there is every possibility that without news, there will be further drifting in the price

the drewster
08/6/2017
13:35
Impatience. People expect developments every week.
mrangry2
08/6/2017
12:08
Jam tomorrow (still) which will always leave people to wonder IF commercial traction can beat the arrival of newer better options.
the drewster
08/6/2017
11:03
Any ideas on why the share price is falling, given the good news flow?
lantanatony
26/5/2017
18:37
impressive video, very exciting technology. Thanks again for posting.
tratante
22/5/2017
14:42
Alistair is very decent, approachable and scientific. Strengthening the board with business brains was, in my view, very astute.

We're certainly "getting there", and each deal, commercials undisclosed or not, MUST improve the cash position.

the drewster
22/5/2017
14:21
That would be great, cheers.
tratante
22/5/2017
14:11
I shall do

It will follow but not now as I'm on my I phone and at work so need to wait till get home

escapetohome
22/5/2017
13:11
Escape, would you be kind enough to post details of the whereabouts of the presentation, or a link? Just arrived on this bb. Thanks.
tratante
22/5/2017
12:28
I think Alistair Smith is a good presenter.

This man knows his stuff and he talks clearly, he cannot be fased.

I think he is GSK material.

escapetohome
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older

Your Recent History

Delayed Upgrade Clock